Our injectable portfolio includes small molecules, peptides & recombinant proteins. These products would be manufactured in our 'Fill & Finish' sterile plant.

Product Strength
Octreotide Injection 50, 100, 500mcg/ml single dose (1ml in 2ml Vial)
Octreotide Injection 200, 1000mcg/ml Multidose Vial (5ml Vial)
Zoledronic Acid Injection 4mg/5ml vial
Palonosetron injection 0.25mg/5ml Vial
Icatibant Acetate Injection 30mg/ 3ml PFS
Peg Filgrastim injection 6mg/0.6m PFS
Sugammadex Sodium Injection 100mg/ml - 2ml & 5ml vial
Regadenoson Monohydrate Injection 0.4mg/5ml
Glycopyrrolate Injection 0.2mg/ml in 1ml, 2ml, 5ml & 20ml vial
Etelcalcetide Injection 2.5mg/0.5ml, 5 mg/ml, 10 mg/2ml

Injectable US: filed 9 ANDAs, 4 approved, 3 commercial, 5 under review

Injectable EU: 3 Filed, 3 approved, 1 commercial

Injectable UK: 4 Filed, 4 approved, 2 commercial

njectable CA: 2 Filed, 1 approved

Injectable Emerging market: 30 Filed, 15 approved, 12 commercial

For more information about our existing portfolio and our pipeline products please e-mail us at

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.

© 2024 USV Private Limited. All Rights Reserved.